Artificial Intelligence System to Determine Risk of T1 Colorectal Cancer Metastasis to Lymph Node.
By: Shin-Ei Kudo, Katsuro Ichimasa, Benjamin Villard, Yuichi Mori, Masashi Misawa, Shoichi Saito, Kinichi Hotta, Yutaka Saito, Takahisa Matsuda, Kazutaka Yamada, Toshifumi Mitani, Kazuo Ohtsuka, Akiko Chino, Daisuke Ide, Kenichiro Imai, Yoshihiro Kishida, Keiko Nakamura, Yasumitsu Saiki, Masafumi Tanaka, Shu Hoteya, Satoshi Yamashita, Yusuke Kinugasa, Masayoshi Fukuda, Toyoki Kudo, Hideyuki Miyachi, Fumio Ishida, Hayato Itoh, Masahiro Oda, Kensaku Mori

Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan. Electronic address: kudos@med.showa-u.ac.jp.
2020-01-29; doi: 10.1053/j.gastro.2020.09.027
Abstract

Background

In accordance with guidelines, most patients with T1 colorectal cancers (CRC) undergo surgical resection with lymph node dissection, despite the low incidence (∼10%) of metastasis to lymph node. To reduce unnecessary surgical resections, we used artificial intelligence to build a model to identify T1 colorectal tumors at risk for metastasis to lymph node and validated the model in a separate set of patients.

Methods

We collected data from 3134 patients with T1 CRC treated at 6 hospitals in Japan from April 1997 through September 2017 (training cohort). We developed a machine-learning artificial neural network (ANN) using data on patients' age and sex, as well as tumor size, location, morphology, lymphatic and vascular invasion, and histologic grade. We then conducted the external validation on the ANN model using independent 939 patients at another hospital during the same period (validation cohort). We calculated areas under the receiver operator characteristics curves (AUROCs) for the ability of the model and United States guidelines to identify patients with lymph node metastases.

Results

Lymph node metastases were found in 319/3134 patients (10.2%) in the training cohort and 79/939 patients (8.4%) in the validation cohort. In the validation cohort, the ANN model identified patients with lymph node metastases with an AUC of 0.83, whereas the guidelines identified patients with lymph node metastases with an AUC of 0.73 (P<.001). When the analysis was limited to patients with initial endoscopic resection (n=517), the ANN model identified patients with lymph node metastases with an AUC of 0.84 and the guidelines identified these patients with an AUC of 0.77 (P=.005).

Conclusions

The ANN model outperformed guidelines in identifying patients with T1 CRCs who had lymph node metastases. This model might be used to determine which patients require additional surgery after endoscopic resection of T1 CRCs. UMIN Clinical Trials Registry no: UMIN000038609.



Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

PMID:32979355






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements